A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

NCT05717166 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Tumor

Interventions

RADIATION: Palliative Radiotherapy
DRUG: Chemotherapy
DRUG: Hormone therapy
DRUG: Immunotherapy
DRUG: Targeted Systemic Therapy
OTHER: Observation
RADIATION: Stereotactic Ablative Radiotherapy
PROCEDURE: Surgery
OTHER: Radiofrequency Therapy (RFA)
RADIATION: Fractionated Radiation

Sponsor

David Palma